Kyowa Hakko to unveil new Cognizin research on acute cognitive effects at ISSN 2026
Kyowa Hakko will present proof-of-concept research at the ISSN Annual Conference exploring the acute effects of a single 500 mg dose of Cognizin Citicoline on brain activity, cognitive performance and mood in healthy adults